Literature DB >> 3152525

Hereditary intestinal neurofibromatosis. I. A distinctive genetic disease.

R Heimann1, A Verhest, J Verschraegen, W Grosjean, J P Draps, F Hecht.   

Abstract

Intestinal neurofibromatosis without other manifestations of von Recklinghausen's neurofibromatosis was found in a multigeneration family. Neurofibromas were strictly limited to the intestine. Onset of symptoms was delayed until adulthood and some gene carriers remained asymptomatic into their middle or late adult years. One other family with intestinal neurofibromatosis has been described in 1966. No symptomatic male is yet known, although an asymptomatic male in our family is an obligate gene carrier. The gene for intestinal neurofibromatosis may be incompletely penetrant and its expression varies even in symptomatic patients. No male-to-male transmission has been recorded to rule out X linkage. Intestinal neurofibromatosis presents as a distinctive dominant phenotype with an increased risk of intestinal problems including bleeding, intussusception and obstruction.

Entities:  

Mesh:

Year:  1988        PMID: 3152525

Source DB:  PubMed          Journal:  Neurofibromatosis        ISSN: 1010-5662


  4 in total

1.  Abdominal neurofibromatosis.

Authors:  M R Thornton; F Campbell; C J Garvey; M J Hershman
Journal:  J R Soc Med       Date:  1999-11       Impact factor: 5.344

2.  PDGFRA-mutant syndrome.

Authors:  Riccardo Ricci; Maurizio Martini; Tonia Cenci; Arnaldo Carbone; Paola Lanza; Alberto Biondi; Guido Rindi; Alessandra Cassano; Alberto Larghi; Roberto Persiani; Luigi M Larocca
Journal:  Mod Pathol       Date:  2015-05-15       Impact factor: 7.842

Review 3.  Diffuse ganglioneuromatosis with plexiform neurofibromas limited to the gastrointestinal tract involving a large segment of small intestine.

Authors:  K Hirata; K Kitahara; Y Momosaka; H Kouho; N Nagata; H Hashimoto; H Itoh
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

Review 4.  Syndromic gastrointestinal stromal tumors.

Authors:  Riccardo Ricci
Journal:  Hered Cancer Clin Pract       Date:  2016-07-19       Impact factor: 2.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.